Detailed Information on Publication Record
2022
Myopia Control in European Children - Study Protocol and Methodology
KOMÍNEK, Martin, Rudolf AUTRATA, Inka KREJČÍŘOVÁ, Barbora ŽAJDLÍKOVÁ, J. HEISSIGEROVÁ et. al.Basic information
Original name
Myopia Control in European Children - Study Protocol and Methodology
Authors
KOMÍNEK, Martin (203 Czech Republic, guarantor, belonging to the institution), Rudolf AUTRATA (203 Czech Republic, belonging to the institution), Inka KREJČÍŘOVÁ (203 Czech Republic, belonging to the institution), Barbora ŽAJDLÍKOVÁ (203 Czech Republic, belonging to the institution), J. HEISSIGEROVÁ (203 Czech Republic), M. KORBASOVÁ (203 Czech Republic), P. STUDENÝ (203 Czech Republic), M. DOSTÁLEK (203 Czech Republic), M. HLOŽÁNEK (203 Czech Republic) and Jana UNAR VINKLEROVÁ (203 Czech Republic, belonging to the institution)
Edition
HSOA Journal of Neonatology and Clinical Pediatrics, Herndon, VA 20171, USA, Herald Scholarly Open Access, 2022, 2378-878X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30230 Other clinical medicine subjects
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14110/22:00127211
Organization unit
Faculty of Medicine
Keywords (in Czech)
Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia
Keywords in English
Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia
Tags
Tags
International impact, Reviewed
Změněno: 26/1/2023 13:13, Mgr. Tereza Miškechová
Abstract
V originále
Purpose To report study protocol and methodology of multicentre, Randomized, double-blind, placebo-controlled study of the efficacy and safety of low dose atropine eye drops (0.02%, 0.04%) in slowing the progression of short-sightedness (myopia) in children. M.A.R.S. (Myopia and Atropin ReStriction). Conclusion M.A.R.S. clinical trial will enrich the knowledge about myopia and its possible treatment in the early stages in European children. It will be beneficial for paediatric patients, practicing paediatricians and ophthalmologist. In the future it will be helpful not only from a medical point of view, but also in economic aspect of management of progression of myopia in children and all the entire population.
Links
NU21-07-00189, research and development project |
| ||
90128, large research infrastructures |
|